J Korean Soc Biol Psychiatry.  2002 Jul;9(1):25-33.

The Use of Pharmacogenomic Method for the Prediction of Antidepressant Responsiveness

Abstract

Serotonin transporter(5-HTT) is one of the major action site of antidepressants in neuronal cells. According to the recent studies, it is known that the functional polymorphism in the promoter region of the 5-HTT gene(5-HTT linked polymorphism repetitive element in promoter region, 5-HTTLPR) is a associated with antidepressant responsiveness, and the distributions of 5-HTTLPR is various among the different population. Our preliminary study suggested that it is possible to measure the endophenotype of 5-HTTLPR genotype by examining the pharmacodynamic research of th 5-HTT in platelet membranes. However, there are limitations to predicting the antidepressant responsiveness only from the endophenotypic characteristics of 5-HTT gene promoter polymorphism, and therefore we propose to use the pharmacogenomic methods for overcoming these limitations. We found that the significant correlations existed among the genetic polymorphisms of biogenic amine transporters whose structure and characteristics are similar to the 5-HTT, and the predictable odds ratio of antidepressant responsiveness are increased significantly by combining the effect with other associated polymorphisms, compared to the effect of 5-HTT promoter polymorphism only. These results support the hypothesis that antidepressant treatment has to be individualized according to the genetic and ethnic background of depressed patients. It would be possible to develope the evaluation tools to predict the antidepressant responsiveness and its side effect profile, if scientists reveal the genes related to the action mechanism as well as the metabolism of antidepressants so as to discover the interaction of those genes and contribution of endogenotypes toward antidepressant responsiveness.


MeSH Terms

Antidepressive Agents
Biogenic Amines
Blood Platelets
Endophenotypes
Genotype
Humans
Membranes
Metabolism
Neurons
Odds Ratio
Pharmacogenetics
Polymorphism, Genetic
Promoter Regions, Genetic
Serotonin
Serotonin Plasma Membrane Transport Proteins
Antidepressive Agents
Biogenic Amines
Serotonin
Serotonin Plasma Membrane Transport Proteins
Full Text Links
  • JKJBP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr